Micot
Xixian
About Micot
Micot is a new molecular entity drug developer for peptides, dedicated to the development of innovative drugs, multi- and protein-based innovative biopharmaceuticals, vaccines and biomolecular drug delivery systems and products, and for drug screening and biopharmaceutical research. The technology combines to provide users with Bio-Res-Deliv, a biological macromolecular respiratory drug delivery system, suitable for the treatment of cardiovascular diseases, metabolic diseases, liver diseases and the like.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $114.4M
- Funding stage: Late Stage Venture
- Last round: Series D (Oct 2025)
- Website: micot.cn
- Phone: 029-89303986
Industries & Categories
Health Care, Medical
Canonical: https://fsome.com/organization/micot-66930 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.